Patent · US Active

Compositions and methods for enhancing coagulation factor VIII function

US9670267B2 · kind B2 · utility

1Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 25, 2014
Grant dateJun 6, 2017
Priority date—
Expiry dateOct 9, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Factor VIII variants and methods of use thereof are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.